Scheraga RG - Search Results

1

Vasopressin Plasma Concentrations Are Not Associated with Hemodynamic Response to Exogenous Vasopressin for Septic Shock.

Yerke JR, Sacha GL, Scheraga RG, Culver DA, Abraham S, Torbic H, Lam SW, Ammar MA, Olman MA, Bauer SR. Yerke JR, et al. Among authors: scheraga rg. Pharmacotherapy. 2020 Jan;40(1):33-39. doi: 10.1002/phar.2346. Epub 2019 Nov 28. Pharmacotherapy. 2020. PMID: 31705703 Free PMC article.

2

TRPV4 Mechanosensitive Ion Channel Regulates Lipopolysaccharide-Stimulated Macrophage Phagocytosis.

Scheraga RG, Abraham S, Niese KA, Southern BD, Grove LM, Hite RD, McDonald C, Hamilton TA, Olman MA. Scheraga RG, et al. J Immunol. 2016 Jan 1;196(1):428-36. doi: 10.4049/jimmunol.1501688. Epub 2015 Nov 23. J Immunol. 2016. PMID: 26597012 Free PMC article.

3

Matrix-driven Myosin II Mediates the Pro-fibrotic Fibroblast Phenotype.

Southern BD, Grove LM, Rahaman SO, Abraham S, Scheraga RG, Niese KA, Sun H, Herzog EL, Liu F, Tschumperlin DJ, Egelhoff TT, Rosenfeld SS, Olman MA. Southern BD, et al. Among authors: scheraga rg. J Biol Chem. 2016 Mar 18;291(12):6083-95. doi: 10.1074/jbc.M115.712380. Epub 2016 Jan 13. J Biol Chem. 2016. PMID: 26763235 Free PMC article.

4

Impaired AMPK Activity Drives Age-Associated Acute Lung Injury after Hemorrhage.

Southern BD, Scheraga RG, Olman MA. Southern BD, et al. Among authors: scheraga rg. Am J Respir Cell Mol Biol. 2017 May;56(5):553-555. doi: 10.1165/rcmb.2017-0023ED. Am J Respir Cell Mol Biol. 2017. PMID: 28459384 Free PMC article. No abstract available.

5

The Role of Transient Receptor Potential Vanilloid 4 in Pulmonary Inflammatory Diseases.

Scheraga RG, Southern BD, Grove LM, Olman MA. Scheraga RG, et al. Front Immunol. 2017 May 4;8:503. doi: 10.3389/fimmu.2017.00503. eCollection 2017. Front Immunol. 2017. PMID: 28523001 Free PMC article. Review.

6

Asthma predisposition and respiratory syncytial virus infection modulate transient receptor potential vanilloid 1 function in children's airways.

Harford TJ, Rezaee F, Scheraga RG, Olman MA, Piedimonte G. Harford TJ, et al. Among authors: scheraga rg. J Allergy Clin Immunol. 2018 Jan;141(1):414-416.e4. doi: 10.1016/j.jaci.2017.07.015. Epub 2017 Oct 2. J Allergy Clin Immunol. 2018. PMID: 28982576 Free PMC article. No abstract available.

7

Choice of antifibrotic medication and disease severity predict weight loss in idiopathic pulmonary fibrosis.

Perelas A, Glennie J, van Kerkhove K, Li M, Scheraga RG, Olman MA, Culver DA. Perelas A, et al. Among authors: scheraga rg. Pulm Pharmacol Ther. 2019 Dec;59:101839. doi: 10.1016/j.pupt.2019.101839. Epub 2019 Sep 10. Pulm Pharmacol Ther. 2019. PMID: 31518649 Free PMC article.

8

A Focus on "Eye on" Channels in Pulmonary Fibrosis.

Scheraga RG, Olman MA. Scheraga RG, et al. Am J Respir Cell Mol Biol. 2020 Feb;62(2):132-133. doi: 10.1165/rcmb.2019-0343ED. Am J Respir Cell Mol Biol. 2020. PMID: 31622111 Free PMC article. No abstract available.

9

Translocation of TRPV4-PI3Kγ complexes to the plasma membrane drives myofibroblast transdifferentiation.

Grove LM, Mohan ML, Abraham S, Scheraga RG, Southern BD, Crish JF, Naga Prasad SV, Olman MA. Grove LM, et al. Among authors: scheraga rg. Sci Signal. 2019 Nov 12;12(607):eaau1533. doi: 10.1126/scisignal.aau1533. Sci Signal. 2019. PMID: 31719171 Free PMC article.

10

TRPV4 Protects the Lung from Bacterial Pneumonia via MAPK Molecular Pathway Switching.

Scheraga RG, Abraham S, Grove LM, Southern BD, Crish JF, Perelas A, McDonald C, Asosingh K, Hasday JD, Olman MA. Scheraga RG, et al. J Immunol. 2020 Mar 1;204(5):1310-1321. doi: 10.4049/jimmunol.1901033. Epub 2020 Jan 22. J Immunol. 2020. PMID: 31969384 Free PMC article.

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My NCBI Filters

Text availability

Article attribute

Article type

Publication date

30 results

Search Page